ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.210,48
0,58%
S&P 500
5.187,70
0,13%
US Dollar vs BRL
5,0747
0,00%
Bitcoin
62.268,23
-0,11%
Brent Oil
82,25
-0,74%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Titan Pharmaceuticals Inc (TTNP)

  7. Titan Pharmaceuticals Inc (TTNP) Notícias

TTNP

Titan Pharmaceuticals (TTNP)

Titan Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TTNP
DataHoraFonteTítuloCódigoCompanhia
25/01/202418:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
25/01/202418:29GlobeNewswire Inc.Titan Pharmaceuticals Fully Compliant With NASDAQ Listing CriteriaNASDAQ:TTNPTitan Pharmaceuticals Inc
28/12/202318:15GlobeNewswire Inc.Titan Pharmaceuticals Announces Reverse Stock Split and RatioNASDAQ:TTNPTitan Pharmaceuticals Inc
28/11/202318:47Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TTNPTitan Pharmaceuticals Inc
17/11/202318:03Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TTNPTitan Pharmaceuticals Inc
26/10/202317:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
24/10/202318:26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TTNPTitan Pharmaceuticals Inc
23/10/202316:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
16/10/202317:37GlobeNewswire Inc.Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of DirectorsNASDAQ:TTNPTitan Pharmaceuticals Inc
04/10/202318:30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TTNPTitan Pharmaceuticals Inc
19/09/202317:41Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
18/09/202308:30GlobeNewswire Inc.Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred StockNASDAQ:TTNPTitan Pharmaceuticals Inc
14/08/202318:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TTNPTitan Pharmaceuticals Inc
31/07/202320:45Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
27/07/202308:30GlobeNewswire Inc.Titan Pharmaceuticals Announces Sale of Certain ProNeura AssetsNASDAQ:TTNPTitan Pharmaceuticals Inc
23/06/202317:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TTNPTitan Pharmaceuticals Inc
23/06/202317:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TTNPTitan Pharmaceuticals Inc
19/05/202310:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
19/05/202310:23Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
15/05/202317:22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TTNPTitan Pharmaceuticals Inc
11/04/202317:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TTNPTitan Pharmaceuticals Inc
31/03/202317:36Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TTNPTitan Pharmaceuticals Inc
15/12/202209:00GlobeNewswire Inc.Titan Pharmaceuticals Provides Shareholder UpdateNASDAQ:TTNPTitan Pharmaceuticals Inc
12/12/202209:49GlobeNewswire Inc.UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.NASDAQ:TTNPTitan Pharmaceuticals Inc
30/08/202217:03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TTNPTitan Pharmaceuticals Inc
16/08/202211:53PR Newswire (US)Titan Pharmaceuticals Announces Board Expansion and Management ChangesNASDAQ:TTNPTitan Pharmaceuticals Inc
25/07/202215:05Edgar (US Regulatory)Proxy Statement - Non-management (definitive) (defn14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
14/07/202213:48Edgar (US Regulatory)Proxy Statements Not Involving Contested Solicitations (preliminary) (pren14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
11/07/202217:00Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
11/07/202209:00GlobeNewswire Inc.Activist Investing Nominates Slate of Highly Qualified Director Candidates for Election to the Board of Directors of Titan Pharmaceuticals at Upcoming Special Meeting of StockholdersNASDAQ:TTNPTitan Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:TTNP

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
VVEO3
CM Hospitalar ON
BOV
CRFB3
CARREFOUR ON
BOV
ETER3
ETERNIT ON
BOV
AZEV4
AZEVEDO PN
BOV
TELB4
TELEBRAS PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados